PUBLISHER: KBV Research | PRODUCT CODE: 1292552
PUBLISHER: KBV Research | PRODUCT CODE: 1292552
LAMEA Antacids Market Size, Share & Industry Trends Analysis Report By Formulation Type (Tablets, Liquids and Others), By Mechanism of Action (Non-systemic and Systemic), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029
The Latin America, Middle East and Africa Antacids Market would witness market growth of 5.1% CAGR during the forecast period (2023-2029).
A significant risk factor for GERD is obesity. Hiatal hernias are caused when excess abdominal fat presses on the stomach, which in turn causes stomach acid to leak into the food pipe. In addition, people who are obese have a higher risk of acid reflux because their lower esophageal sphincter (LES) relaxes to a greater extent. Acidity or gastroesophageal reflux disease (GERD) affects a large proportion of obese people and people with high BMIs. In addition to gastroesophageal reflux disease (GERD), obesity is linked to a wide variety of disorders, the treatment for which may involve the use of over-the-counter drugs such as antacids.
Bad eating practices, sedentary lifestyles, and frequent use of drugs to control high blood pressure are a few of the factors contributing to the rise in antacid demand. As a result, market players are spending a lot of money on research and development projects to distinguish their products by creating powerful antacids. Manufacturers present in the market are adopting newer drug formulation approaches in the form of chewable and flavored pills, which are focused on the needs of the consumer.
The percentage of overweight or obese adults and children in Israel has increased. Obesity affects 13.7% of persons over 18, while overweight affects 34% of the nation. Obesity develops when there is an imbalance between the calories consumed and the energy expended during activity. High-calorie fast food, bigger portions, and the affordability of high-calorie meals are the usual sources of excess calories. At the same time, less physical activity has been reported as a result of individuals spending more time watching television, operating computers, and utilizing other electronics. In addition, the number of individuals with digestive tract issues is predicted to rise due to rising obesity for a variety of causes, which will also accelerate market growth in the region.
The Brazil market dominated the LAMEA Antacids Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $136.4 Million by 2029. The Argentina market is experiencing a CAGR of 5.7% during (2023 - 2029). Additionally, The UAE market would display a CAGR of 4.8% during (2023 - 2029).
Based on Formulation Type, the market is segmented into Tablets, Liquids and Others. Based on Mechanism of Action, the market is segmented into Non-systemic and Systemic. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Alkem Laboratories Ltd., Bayer AG, Cipla Limited, Pfizer, Inc., Prestige Consumer Healthcare, Inc., Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation (Avista Capital Partners), Sanofi S.A. and Sun Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments covered in the Report:
By Formulation Type
- Tablets
- Liquids
- Others
By Mechanism of Action
- Non-systemic
- Systemic
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- Alkem Laboratories Ltd.
- Bayer AG
- Cipla Limited
- Pfizer, Inc.
- Prestige Consumer Healthcare, Inc.
- Reckitt Benckiser Group PLC
- WellSpring Pharmaceutical Corporation (Avista Capital Partners)
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Antacids Market, by Formulation Type
- 1.4.2 LAMEA Antacids Market, by Mechanism of Action
- 1.4.3 LAMEA Antacids Market, by Distribution Channel
- 1.4.4 LAMEA Antacids Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. LAMEA Antacids Market by Formulation Type
- 3.1 LAMEA Tablets Market by Country
- 3.2 LAMEA Liquids Market by Country
- 3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Antacids Market by Mechanism of Action
- 4.1 LAMEA Non-systemic Market by Country
- 4.2 LAMEA Systemic Market by Country
Chapter 5. LAMEA Antacids Market by Distribution Channel
- 5.1 LAMEA Drug Store & Retail Pharmacies Market by Country
- 5.2 LAMEA Hospital Pharmacies Market by Country
- 5.3 LAMEA Online Pharmacies Market by Country
Chapter 6. LAMEA Antacids Market by Country
- 6.1 Brazil Antacids Market
- 6.1.1 Brazil Antacids Market by Formulation Type
- 6.1.2 Brazil Antacids Market by Mechanism of Action
- 6.1.3 Brazil Antacids Market by Distribution Channel
- 6.2 Argentina Antacids Market
- 6.2.1 Argentina Antacids Market by Formulation Type
- 6.2.2 Argentina Antacids Market by Mechanism of Action
- 6.2.3 Argentina Antacids Market by Distribution Channel
- 6.3 UAE Antacids Market
- 6.3.1 UAE Antacids Market by Formulation Type
- 6.3.2 UAE Antacids Market by Mechanism of Action
- 6.3.3 UAE Antacids Market by Distribution Channel
- 6.4 Saudi Arabia Antacids Market
- 6.4.1 Saudi Arabia Antacids Market by Formulation Type
- 6.4.2 Saudi Arabia Antacids Market by Mechanism of Action
- 6.4.3 Saudi Arabia Antacids Market by Distribution Channel
- 6.5 South Africa Antacids Market
- 6.5.1 South Africa Antacids Market by Formulation Type
- 6.5.2 South Africa Antacids Market by Mechanism of Action
- 6.5.3 South Africa Antacids Market by Distribution Channel
- 6.6 Nigeria Antacids Market
- 6.6.1 Nigeria Antacids Market by Formulation Type
- 6.6.2 Nigeria Antacids Market by Mechanism of Action
- 6.6.3 Nigeria Antacids Market by Distribution Channel
- 6.7 Rest of LAMEA Antacids Market
- 6.7.1 Rest of LAMEA Antacids Market by Formulation Type
- 6.7.2 Rest of LAMEA Antacids Market by Mechanism of Action
- 6.7.3 Rest of LAMEA Antacids Market by Distribution Channel
Chapter 7. Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
- 7.2 Alkem Laboratories Ltd.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.3 Bayer AG
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 SWOT Analysis
- 7.4 Cipla Limited
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expense
- 7.5 Pfizer, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional & Segmental Analysis
- 7.5.4 Research & Development Expense
- 7.6 Prestige Consumer Healthcare, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.7 Reckitt Benckiser Group PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.8 WellSpring Pharmaceutical Corporation (Avista Capital Partners)
- 7.8.1 Company Overview
- 7.9 Sanofi S.A.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.10. Sun Pharmaceutical Industries Ltd.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional Analysis
- 7.10.4 Research & Development Expenses
LIST OF TABLES
- TABLE 1 LAMEA Antacids Market, 2019 - 2022, USD Million
- TABLE 2 LAMEA Antacids Market, 2023 - 2029, USD Million
- TABLE 3 LAMEA Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 4 LAMEA Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 5 LAMEA Tablets Market by Country, 2019 - 2022, USD Million
- TABLE 6 LAMEA Tablets Market by Country, 2023 - 2029, USD Million
- TABLE 7 LAMEA Liquids Market by Country, 2019 - 2022, USD Million
- TABLE 8 LAMEA Liquids Market by Country, 2023 - 2029, USD Million
- TABLE 9 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 10 LAMEA Others Market by Country, 2023 - 2029, USD Million
- TABLE 11 LAMEA Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 12 LAMEA Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 13 LAMEA Non-systemic Market by Country, 2019 - 2022, USD Million
- TABLE 14 LAMEA Non-systemic Market by Country, 2023 - 2029, USD Million
- TABLE 15 LAMEA Systemic Market by Country, 2019 - 2022, USD Million
- TABLE 16 LAMEA Systemic Market by Country, 2023 - 2029, USD Million
- TABLE 17 LAMEA Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 18 LAMEA Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 19 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 20 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
- TABLE 21 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 22 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
- TABLE 23 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 24 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
- TABLE 25 LAMEA Antacids Market by Country, 2019 - 2022, USD Million
- TABLE 26 LAMEA Antacids Market by Country, 2023 - 2029, USD Million
- TABLE 27 Brazil Antacids Market, 2019 - 2022, USD Million
- TABLE 28 Brazil Antacids Market, 2023 - 2029, USD Million
- TABLE 29 Brazil Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 30 Brazil Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 31 Brazil Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 32 Brazil Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 33 Brazil Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 34 Brazil Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 35 Argentina Antacids Market, 2019 - 2022, USD Million
- TABLE 36 Argentina Antacids Market, 2023 - 2029, USD Million
- TABLE 37 Argentina Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 38 Argentina Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 39 Argentina Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 40 Argentina Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 41 Argentina Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 42 Argentina Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 43 UAE Antacids Market, 2019 - 2022, USD Million
- TABLE 44 UAE Antacids Market, 2023 - 2029, USD Million
- TABLE 45 UAE Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 46 UAE Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 47 UAE Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 48 UAE Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 49 UAE Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 50 UAE Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 51 Saudi Arabia Antacids Market, 2019 - 2022, USD Million
- TABLE 52 Saudi Arabia Antacids Market, 2023 - 2029, USD Million
- TABLE 53 Saudi Arabia Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 54 Saudi Arabia Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 55 Saudi Arabia Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 56 Saudi Arabia Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 57 Saudi Arabia Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 58 Saudi Arabia Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 59 South Africa Antacids Market, 2019 - 2022, USD Million
- TABLE 60 South Africa Antacids Market, 2023 - 2029, USD Million
- TABLE 61 South Africa Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 62 South Africa Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 63 South Africa Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 64 South Africa Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 65 South Africa Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 66 South Africa Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 67 Nigeria Antacids Market, 2019 - 2022, USD Million
- TABLE 68 Nigeria Antacids Market, 2023 - 2029, USD Million
- TABLE 69 Nigeria Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 70 Nigeria Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 71 Nigeria Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 72 Nigeria Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 73 Nigeria Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 74 Nigeria Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 75 Rest of LAMEA Antacids Market, 2019 - 2022, USD Million
- TABLE 76 Rest of LAMEA Antacids Market, 2023 - 2029, USD Million
- TABLE 77 Rest of LAMEA Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 78 Rest of LAMEA Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 79 Rest of LAMEA Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 80 Rest of LAMEA Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 81 Rest of LAMEA Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 82 Rest of LAMEA Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 83 Key Information - Abbott Laboratories
- TABLE 84 Key Information - Alkem Laboratories Ltd.
- TABLE 85 Key Information - Bayer AG
- TABLE 86 Key Information - Cipla Limited
- TABLE 87 Key Information - Pfizer, Inc.
- TABLE 88 Key Information - Prestige Consumer Healthcare, Inc.
- TABLE 89 Key information - Reckitt Benckiser Group PLC
- TABLE 90 Key Information - WellSpring Pharmaceutical Corporation
- TABLE 91 Key Information - Sanofi S.A.
- TABLE 92 Key Information - Sun Pharmaceutical Industries Ltd.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 LAMEA Antacids Market share by Formulation Type, 2022
- FIG 3 LAMEA Antacids Market share by Formulation Type, 2029
- FIG 4 LAMEA Antacids Market by Formulation Type, 2019 - 2029, USD Million
- FIG 5 LAMEA Antacids Market share by Mechanism of Action, 2022
- FIG 6 LAMEA Antacids Market share by Mechanism of Action, 2029
- FIG 7 LAMEA Antacids Market by Mechanism of Action, 2019 - 2029, USD Million
- FIG 8 LAMEA Antacids Market share by Distribution Channel, 2022
- FIG 9 LAMEA Antacids Market share by Distribution Channel, 2029
- FIG 10 LAMEA Antacids Market by Distribution Channel, 2019 - 2029, USD Million
- FIG 11 LAMEA Antacids Market share by Country, 2022
- FIG 12 LAMEA Antacids Market share by Country, 2029
- FIG 13 LAMEA Antacids Market by Country, 2019 - 2029, USD Million
- FIG 14 Swot analysis: Abbott laboratories
- FIG 15 Swot analysis: bayer ag
